How to Talk so Someone With Addiction Will Listen (clinicians)

I contend that the outcome of a given treatment episode is often determined right at the outset, based on why the clients is in treatment in the first place.

The physician, meanwhile, depends on the information provided by medical science, usually in the form of materials from the pharma firm that markets the product.

The benefits needn’t be long-lasting, just readily accessible when you discover you need them.

If the dose is in fact subtherapeutic, then what causes the effects so enthusiastically reported by the user?

Those of us who work in treatment quickly sense a problem: people with addictions aren’t likely to respond to this approach.

…in many instance, it’ll be an unfair fight between enormously well-funded, politically savvy industry lobbies and a few determined nonprofits that advocate for public health.

Suppose we could develop cognitive techniques and train the patient to use them whenever symptoms reappeared?

The relative importance of set and setting suggests that the environment in an LSD experience should be carefully controlled.

A better approach is to seek out the motivation behind the belief.

Here’s something else familiar: That preoccupation with obtaining and protecting the supply.